Skip to main content
. 2023 Dec 13;274(5):1153–1165. doi: 10.1007/s00406-023-01720-9

Table 2.

Study assessment overview

Study inclusion After 4 weeks Yearly follow up until 5 years
Observer rating

MADRS, GAF

SIMPAQ, expert rating, SCID-CV

MADRS, GAF

SIMPAQ

MADRS, GAF

SIMPAQ, expert rating,

Self-rating questionnaires Large questionnaire profile1 Small questionnaire profile2 Large questionnaire profile1
HRV measurements At least 10 min (5 min supine/sitting each) At least 10 min (5 min supine/sitting each) At least 10 min (5 min supine/sitting each)
Bioimpedance scale Tanita scale Tanita scale Tanita Scale
Laboratory assessments Multiplex analysis, blood collection3 Multiplex analysis, blood collection3 Blood collection3
Vital parameters Blood pressure, temperature, pulse Blood pressure, temperature, pulse Blood pressure, temperature, pulse

Large questionnaire profile1: socio-demographic data, family history, medical history, PHQ-9, PHQ-15, MCTQ, GAD-7, postal code, PID5BF + M, WHO-DAS, FEV, CTS, CTQ, PC-PTSD, PACIC, FEV, WHO-5, LSNS 6, BRS, UCLA LS 3, SSD-12, IDS-SR small questionnaire profile2: HTQ, PHQ-9, PHQ-15, MCTQ, GAD-7, WHO-DAS, FEV, SSD-12, IDS-SR Blood Collection3: fasting glucose, triglycerides, morning cortisol, CRP, AAT-1, IGF-1, cortisol, TSH, complete blood count, HbA1c, liver values